{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:59:41Z","timestamp":1781877581445,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05593-z","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:43:29Z","timestamp":1781876609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Standardizing PSMA PET\/CT reporting in prostate cancer: from structured frameworks to AI-assisted interpretation"],"prefix":"10.1007","author":[{"given":"Yuki","family":"Arita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moniba","family":"Bijari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andor W. J. M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon J. S.","family":"Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"L\u00fctje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"5593_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00259-024-06857-w","volume":"52","author":"SA Esfahani","year":"2024","unstructured":"Esfahani SA, Morris MJ, Sartor O, et al. (2024) Standardized template for clinical reporting of PSMA PET\/CT scans. European journal of nuclear medicine and molecular imaging 52:335\u2013341. doi:https:\/\/doi.org\/10.1007\/s00259-024-06857-w","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR2","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, et al. (2023) PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. European journal of nuclear medicine and molecular imaging. 50:1466\u20131486. doi:https:\/\/doi.org\/10.1007\/s00259-022-06089-w","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR3","doi-asserted-by":"publisher","first-page":"e250701","DOI":"10.1148\/radiol.250701","volume":"317","author":"S Woo","year":"2025","unstructured":"Woo S, Masci B, Rowe SP, et al. (2025) Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET. Radiology 317:e250701. doi:https:\/\/doi.org\/10.1148\/radiol.250701","journal-title":"Radiology"},{"key":"5593_CR4","doi-asserted-by":"publisher","unstructured":"Gillessen S, Turco F, Davis ID, et al. (2025) Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). European urology 87:157\u2013216. doi:https:\/\/doi.org\/10.1016\/j.eururo.2024.09.017","DOI":"10.1016\/j.eururo.2024.09.017"},{"key":"5593_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2023.02.002","volume":"83","author":"R Seifert","year":"2023","unstructured":"Seifert R, Emmett L, Rowe SP, et al. (2023) Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2). European urology 83:405\u2013412. doi:https:\/\/doi.org\/10.1016\/j.eururo.2023.02.002","journal-title":"European urology"},{"key":"5593_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.eururo.2023.06.008","volume":"84","author":"RA Werner","year":"2023","unstructured":"Werner RA, Hartrampf PE, Fendler WP, et al. (2023) Prostate-specific Membrane Antigen Reporting and Data System Version 2.0. European urology 84:491\u2013502. doi:https:\/\/doi.org\/10.1016\/j.eururo.2023.06.008","journal-title":"European urology"},{"key":"5593_CR7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.2967\/jnumed.119.233817","volume":"61","author":"S Fanti","year":"2020","unstructured":"Fanti S, Hadaschik B, Herrmann K. (2020) Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET\/CT Imaging: The PSMA PET Progression Criteria. Journal of nuclear medicine 61:678\u2013682. doi:https:\/\/doi.org\/10.2967\/jnumed.119.233817","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR8","doi-asserted-by":"publisher","first-page":"e222148","DOI":"10.1148\/radiol.222148","volume":"308","author":"A Gafita","year":"2023","unstructured":"Gafita A, Djaileb L, Rauscher I, et al. (2023) Response Evaluation Criteria in PSMA PET\/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer. Radiology 308:e222148. doi:https:\/\/doi.org\/10.1148\/radiol.222148","journal-title":"Radiology"},{"key":"5593_CR9","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","volume":"48","author":"F Ceci","year":"2021","unstructured":"Ceci F, Oprea-Lager DE, Emmett L, et al. (2021) E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET. Article. European journal of nuclear medicine and molecular imaging 48:1626\u20131638. doi:https:\/\/doi.org\/10.1007\/s00259-021-05245-y","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.semnuclmed.2023.11.001","volume":"54","author":"AF Voter","year":"2024","unstructured":"Voter AF, Werner RA, Savas H, et al. (2024) A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging. Seminars in nuclear medicine 54:119\u2013131. doi:https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.11.001","journal-title":"Seminars in nuclear medicine"},{"key":"5593_CR11","doi-asserted-by":"publisher","first-page":"e250702","DOI":"10.1148\/radiol.250702","volume":"317","author":"HA Vargas","year":"2025","unstructured":"Vargas HA, Fanti S, Herrmann K, et al. (2025) PSMA PET\/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation Frameworks. Radiology 317:e250702. doi:https:\/\/doi.org\/10.1148\/radiol.250702","journal-title":"Radiology"},{"key":"5593_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.euo.2018.11.007","volume":"2","author":"SP Thang","year":"2019","unstructured":"Thang SP, Violet J, Sandhu S, et al. (2019) Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for (177)Lu-labelled PSMA Radioligand Therapy. European urology oncology 2:670\u2013676. doi:https:\/\/doi.org\/10.1016\/j.euo.2018.11.007","journal-title":"European urology oncology"},{"key":"5593_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2967\/jnumed.119.231431","volume":"61","author":"H Rathke","year":"2020","unstructured":"Rathke H, Holland-Letz T, Mier W, et al. (2020) Response Prediction of (177)Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase. Journal of nuclear medicine 61:689\u2013695. doi:https:\/\/doi.org\/10.2967\/jnumed.119.231431","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR14","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.2967\/jnumed.121.263441","volume":"63","author":"M Hotta","year":"2022","unstructured":"Hotta M, Gafita A, Czernin J, Calais J. (2022) Outcome of Patients with PSMA PET\/CT Screen Failure by VISION Criteria and Treated with (177)Lu-PSMA Therapy: A Multicenter Retrospective Analysis. Journal of nuclear medicine 63:1484\u20131488. doi:https:\/\/doi.org\/10.2967\/jnumed.121.263441","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR15","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2967\/jnumed.120.241737","volume":"61","author":"C Ortega","year":"2020","unstructured":"Ortega C, Schaefferkoetter J, Veit-Haibach P, et al. (2020) (18)F-DCFPyL PET\/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smoothing Filter, and Partial-Volume Correction on PROMISE Criteria. Journal of nuclear medicine 61:1615\u20131620. doi:https:\/\/doi.org\/10.2967\/jnumed.120.241737","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00259-017-3740-2","volume":"44","author":"N Aide","year":"2017","unstructured":"Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. (2017) EANM\/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. European journal of nuclear medicine and molecular imaging. 44:17\u201331. doi:https:\/\/doi.org\/10.1007\/s00259-017-3740-2","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR17","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00259-017-3780-7","volume":"44","author":"S Sheikhbahaei","year":"2017","unstructured":"Sheikhbahaei S, Afshar-Oromieh A, Eiber M, et al. (2017) Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging. European journal of nuclear medicine and molecular imaging;44:2117\u20132136. doi:https:\/\/doi.org\/10.1007\/s00259-017-3780-7","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s00261-025-05068-7","volume":"51","author":"A Elsamny","year":"2026","unstructured":"Elsamny A, Wardeh A, Panyukova A, Kandel K, Lubin D, Nicola R. (2026) PSMA-RADS 2.0: a revised framework for PSMA-targeted imaging interpretation and clinical decision-making. Abdominal radiology (New York). 51:180\u2013192. doi:https:\/\/doi.org\/10.1007\/s00261-025-05068-7","journal-title":"Abdominal radiology (New York)"},{"key":"5593_CR19","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2967\/jnumed.121.263072","volume":"63","author":"A Gafita","year":"2022","unstructured":"Gafita A, Rauscher I, Weber M, et al. (2022) Novel Framework for Treatment Response Evaluation Using PSMA PET\/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study. Journal of nuclear medicine 63:1651\u20131658. doi:https:\/\/doi.org\/10.2967\/jnumed.121.263072","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR20","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.2967\/jnumed.121.263448","volume":"63","author":"L Emmett","year":"2022","unstructured":"Emmett L, Papa N, Buteau J, et al. (2022) The PRIMARY Score: Using Intraprostatic (68)Ga-PSMA PET\/CT Patterns to Optimize Prostate Cancer Diagnosis. Journal of nuclear medicine 63:1644\u20131650. doi:https:\/\/doi.org\/10.2967\/jnumed.121.263448","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40336-024-00631-6","volume":"12","author":"S Woo","year":"2024","unstructured":"Woo S, Freedman D, Becker AS, et al. (2024) Equivocal bone lesions on PSMA PET\/CT: systematic review and meta-analysis on their prevalence and malignancy rate. Clinical and Translational Imaging. 12:485\u2013500. doi:https:\/\/doi.org\/10.1007\/s40336-024-00631-6","journal-title":"Clinical and Translational Imaging"},{"key":"5593_CR22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2967\/jnumed.120.258574","volume":"62","author":"M Wondergem","year":"2021","unstructured":"Wondergem M, van der Zant FM, Broos WAM, Knol RJJ. (2021) Matched-Pair Comparison of (18)F-DCFPyL PET\/CT and (18)F-PSMA-1007 PET\/CT in 240 Prostate Cancer Patients: Interreader Agreement and Lesion Detection Rate of Suspected Lesions. Journal of nuclear medicine 62:1422\u20131429. doi:https:\/\/doi.org\/10.2967\/jnumed.120.258574","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2967\/jnumed.119.229187","volume":"61","author":"I Rauscher","year":"2020","unstructured":"Rauscher I, Kr\u00f6nke M, K\u00f6nig M, et al. (2020) Matched-Pair Comparison of (68)Ga-PSMA-11 PET\/CT and (18)F-PSMA-1007 PET\/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical Prostatectomy. Journal of nuclear medicine 61:51\u201357. doi:https:\/\/doi.org\/10.2967\/jnumed.119.229187","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","volume":"20","author":"F de Galiza Barbosa","year":"2020","unstructured":"de Galiza Barbosa F, Queiroz MA, Nunes RF, et al. (2020) Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer imaging 20:23. doi:https:\/\/doi.org\/10.1186\/s40644-020-00300-7","journal-title":"Cancer imaging"},{"key":"5593_CR25","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.2967\/jnumed.117.204677","volume":"59","author":"C Rischpler","year":"2018","unstructured":"Rischpler C, Beck TI, Okamoto S, et al. (2018) (68)Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging. Journal of nuclear medicine 59:1406\u20131411. doi:https:\/\/doi.org\/10.2967\/jnumed.117.204677","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00259-014-2915-3","volume":"42","author":"T Krohn","year":"2015","unstructured":"Krohn T, Verburg FA, Pufe T, et al. (2015) [(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice. European journal of nuclear medicine and molecular imaging 42:210\u20134. doi:https:\/\/doi.org\/10.1007\/s00259-014-2915-3","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR27","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","volume":"44","author":"FL Giesel","year":"2017","unstructured":"Giesel FL, Hadaschik B, Cardinale J, et al. (2017) F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. European journal of nuclear medicine and molecular imaging 44:678\u2013688. doi:https:\/\/doi.org\/10.1007\/s00259-016-3573-4","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR28","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2967\/jnumed.120.252114","volume":"62","author":"T Tolvanen","year":"2021","unstructured":"Tolvanen T, Kalliokoski K, Malaspina S, et al. (2021) Safety, Biodistribution, and Radiation Dosimetry of (18)F-rhPSMA-7.3 in Healthy Adult Volunteers. Journal of nuclear medicine 62:679\u2013684. doi:https:\/\/doi.org\/10.2967\/jnumed.120.252114","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR29","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.2967\/jnumed.120.251447","volume":"62","author":"M Kroenke","year":"2021","unstructured":"Kroenke M, Mirzoyan L, Horn T, et al. (2021) Matched-Pair Comparison of (68)Ga-PSMA-11 and (18)F-rhPSMA-7 PET\/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor Positivity. Journal of nuclear medicine 62:1082\u20131088. doi:https:\/\/doi.org\/10.2967\/jnumed.120.251447","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.08.005","author":"K Herrmann","year":"2025","unstructured":"Herrmann K, Walz J, MacLennan S, et al. (2025) SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography\/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis. European Urology doi:https:\/\/doi.org\/10.1016\/j.eururo.2025.08.005","journal-title":"European Urology"},{"key":"5593_CR31","doi-asserted-by":"publisher","first-page":"153535082412452","DOI":"10.1177\/15353508241245265","volume":"23","author":"SJ Archibald","year":"2024","unstructured":"Archibald SJ, Holland JP, Korde A, Martins AF, Shuhendler AJ, Scott PJH. (2024) Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging. Molecular imaging 23:15353508241245265. doi:https:\/\/doi.org\/10.1177\/15353508241245265","journal-title":"Molecular imaging"},{"key":"5593_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00259-021-05497-8","volume":"49","author":"K Johnsson","year":"2022","unstructured":"Johnsson K, Brynolfsson J, Sahlstedt H, et al. (2022) Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [(18)F]DCFPyL (PSMA) imaging for standardized reporting. European journal of nuclear medicine and molecular imaging. 49:1041\u20131051. doi:https:\/\/doi.org\/10.1007\/s00259-021-05497-8","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR33","doi-asserted-by":"publisher","first-page":"153535082513668","DOI":"10.1177\/15353508251366816","volume":"24","author":"P Ellingson","year":"2025","unstructured":"Ellingson P, Penning J, Cayci Z, Jafari F. (2025) A Novel Approach to Parametric Studies in Nuclear Medicine. Molecular imaging 24:15353508251366816. doi:https:\/\/doi.org\/10.1177\/15353508251366816","journal-title":"Molecular imaging"},{"key":"5593_CR34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40658-025-00786-9","volume":"12","author":"E Tr\u00e4g\u00e5rdh","year":"2025","unstructured":"Tr\u00e4g\u00e5rdh E, Ul\u00e9n J, Enqvist O, et al. (2025) A fully automated AI-based method for tumour detection and quantification on [18F]PSMA-1007 PET-CT images in prostate cancer. EJNMMI physics 12:78. doi:https:\/\/doi.org\/10.1186\/s40658-025-00786-9.","journal-title":"EJNMMI physics"},{"key":"5593_CR35","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1007\/s00259-022-05806-9","volume":"49","author":"E Tr\u00e4g\u00e5rdh","year":"2022","unstructured":"Tr\u00e4g\u00e5rdh E, Enqvist O, Ul\u00e9n J, et al. (2022) Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians. European journal of nuclear medicine and molecular imaging 49:3412\u20133418. doi:https:\/\/doi.org\/10.1007\/s00259-022-05806-9.","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"5593_CR36","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1007\/s00259-023-06382-2","volume":"50","author":"J Kendrick","year":"2023","unstructured":"Kendrick J, Francis RJ, Hassan GM, et al. (2023) Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images. European journal of nuclear medicine and molecular imaging 50:4077\u20134086. doi:https:\/\/doi.org\/10.1007\/s00259-023-06382-2.","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"2","key":"5593_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2967\/jnumed.120.261863","volume":"63","author":"NG Nickols","year":"2022","unstructured":"Nickols NG, Anand A, Johnsson K, et al. (2022) aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL Images of Veterans with Prostate Cancer. Journal of nuclear medicine 63(2):233\u2013239. doi:https:\/\/doi.org\/10.2967\/jnumed.120.261863.","journal-title":"Journal of nuclear medicine"},{"issue":"2","key":"5593_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00259-021-05473-2","volume":"49","author":"N Capobianco","year":"2022","unstructured":"Capobianco N, Varoquaux A, H\u00f8ilund-Carlsen PF, et al. (2022) Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET\/CT using dual-tracer learning. European journal of nuclear medicine and molecular imaging 49(2):517\u2013526. doi:https:\/\/doi.org\/10.1007\/s00259-021-05473-2.","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"1","key":"5593_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13550-022-00948-1","volume":"12","author":"KH Leung","year":"2022","unstructured":"Leung KH, Rowe SP, Leal JP, et al. (2022) Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET. EJNMMI research 12(1):76. doi:https:\/\/doi.org\/10.1186\/s13550-022-00948-1.","journal-title":"EJNMMI research"},{"issue":"3","key":"5593_CR40","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.euo.2024.10.011","volume":"8","author":"CM Benitez","year":"2025","unstructured":"Benitez CM, Sahlstedt H, Sonni I, et al. (2025) Treatment Response Assessment According to Updated PROMISE Criteria in Patients with Metastatic Prostate Cancer Using an Automated Imaging Platform for Identification, Measurement, and Temporal Tracking of Disease. European urology oncology 8(3):700\u2013708. doi:https:\/\/doi.org\/10.1016\/j.euo.2024.10.011.","journal-title":"European urology oncology"},{"issue":"12","key":"5593_CR41","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.2967\/jnumed.125.270242","volume":"66","author":"D Koehler","year":"2025","unstructured":"Koehler D, Shenas F, Sauer M, et al. (2025) PSMA PET Evaluation with a Deep Learning Platform Compared with a Standard Image Viewer and Histopathology. Journal of nuclear medicine 66(12):2014\u20132019. doi:https:\/\/doi.org\/10.2967\/jnumed.125.270242.","journal-title":"Journal of nuclear medicine"},{"key":"5593_CR42","doi-asserted-by":"publisher","first-page":"111265","DOI":"10.1016\/j.radonc.2025.111265","volume":"214","author":"L Zhao","year":"2026","unstructured":"Zhao L, Imami MR, Wang Y, et al. (2026) Artificial intelligence-based lesion characterization and outcome prediction of prostate cancer on [18F]DCFPyL PSMA imaging. Radiotherapy and oncology 214:111265. doi:https:\/\/doi.org\/10.1016\/j.radonc.2025.111265.","journal-title":"Radiotherapy and oncology"},{"key":"5593_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-026-05434-z","author":"S Shojaei","year":"2026","unstructured":"Shojaei S, Yakar D, Vellinga N, Bozgo V, Kwee T, Huisman H, Mifsud Bonnici JP. (2026) The AI Act and the MDR post-market requirements for semiautonomous AI SaMD: a radiology case study in prostate cancer. Abdominal radiology. doi:https:\/\/doi.org\/10.1007\/s00261-026-05434-z.","journal-title":"Abdominal radiology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05593-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05593-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:43:30Z","timestamp":1781876610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05593-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":43,"alternative-id":["5593"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05593-z","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.A. is a Guest Editor for this Special Collection but was not involved in the editorial handling, reviewer selection, or decision-making for this manuscript. The peer-review process was managed independently by other editorial board members to avoid any potential conflict of interest. All other authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}